The ultimate objective in understanding the risk of developing PH in SSc is early diagnosis and early initiation of appropriate therapy with the hope for improved outcomes for patients with SSc-PH. PubMed. Curr Rheumatol Rep. 2013 Jan;15(1):302. (Also see: Pulmonary Hypertension Prognosis, and Prognosis in Systemic Sclerosis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.